The AIM Attraction


Contrary to popular belief, both institutional and private investors do have huge pots of cash for the right companies looking to IPO. 

In this article, Mark Fahy and Marcus Stuttard of the London Stock Exchange talk to Criticaleye about AIM’s enduring strength through the economic downturn and why it can be the perfect home for growth businesses needing an injection of capital.

The article also includes Community Comment from AIM veterans Clive Ansell, Robert Drummond and Faisal Rahmatallah

Share this with your Community


Contributors
Clive Ansell
Non-Executive Director
Eckoh plc
Marcus Stuttard
Head of AIM and UK Primary Markets
London Stock Exchange Group
Mark Fahy
Former Head of UK Small & Mid-Cap Companies

Robert Drummond
Chairman & Non-executive Director
North East Finance


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Inspiring Leaders Podcast: Le...

Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...

Inspiring Leaders Podcast: De...

Lucinda Charles-Jones, Non-executive Director & Chair or RemCo for Virgin Money and Rank Group (plus a Criticaleye Board Mentor) and Jim Devine, Group HRD, Spirax Group speak to us about some of the findings of our ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 305




British Land Lightsource bp Palo Alto Networks Worldpay Legal & General Eightfold AI Workday Salesforce Concentrix Google London Stock Exchange Group NATS Aldermore Group FTSE Women Leaders Review Hitachi Solutions E.ON UK NatWest Group AlixPartners IBM Consulting Rolls-Royce Drax Group plc Accenture GlaxoSmithKline plc